YWYu Wu

Yu Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yu Wu has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Biallelic NPHP3 Variants Causing Late Onset Chronic Kidney Insufficiency in Nephronophthisis: A Case Report

    by Yu Wu, Mengshi Li, Lei Jiang, Xujie Zhou, Yilun Zhou

    Emerging evidence suggests that the overall prevalence of nephronophthisis (NPHP) in adult‐onset end‐stage kidney disease (ESKD) is very likely underestimated. Thus, a comprehensive understanding of the genetic basis and clinicopathologic features of adult‐onset NPHP is essential. In this case, we report a 38‐year‐old woman who exhibited no growth disorders or urinary abnormalities in prior physical examinations. However, at 38 years of age, she presented with renal dysfunction (eGFR 29.5 mL/min/1.73 m 2 ). Urine tests revealed a low specific gravity of urine, but no proteinuria or microscopic hematuria, while urinary (α1‐MG) was elevated (137 mg/L). Extrarenal phenotypes were absent. For a definitive diagnosis, a renal biopsy was conducted. Light microscopic findings showed established irregular microcystic dilatation in the tubules, irregular focal lamellation of the tubular basement membrane and moderate fibrosis in the interstitial area. Genetic analysis identified biallelic NPHP3 variants in trans: c.1047C>A (p.Tyr349Ter) non‐sense variant and c.3725A>G (p.Tyr1242Cys) missense variant., leading to a definitive diagnosis of NPHP. This case highlights NPHP3 as an appreciable genetic cause for adult‐onset nonsyndromic NPHP. Further studies are required to clarify the genotype–phenotype correlations of NPHP in adults.

  • Open Access

    Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial

    by Yu Wu, Yuesong Pan, Mengxing Wang, Xia Meng, Yilong Wang, Shuya Li, Yongjun Wang, Yilun Zhou, Wanliang Du

    Objective: Limited evidence is available regarding the risk-benefit ratio of thrombolytic therapy in patients with stroke and renal impairment complications, particularly for the drug tenecteplase. Therefore, we examined the association of impaired renal function with the safety and efficacy of intravenous thrombolytic treatment (IVT) in patients with acute ischaemic stroke (AIS). Methods: A post hoc analysis of a randomised controlled trial (ClinicalTrials gov. NCT04797013 ) was conducted. Participants who received IVT with tenecteplase and alteplase (0.25 and 0.9 mg/kg, respectively) within 4.5 hours of symptoms onset were categorised based on their estimated glomerular filtration rate as follows: (1) ≥90 mL/min/1.73 m 2 ,normal renal function; (2) 60–89 mL/min/1.73 m 2 , mildly decreased renal function; and (3) 2 , moderately to severely decreased renal function. Patients stratified based on the normal renal function were used as the references. The primary efficacy and safety outcome were the percentage of patients achieving a modified Rankin Scale score of 0–1 at 90 days and the symptomatic intracranial haemorrhage (sICH) occurrence within 36 hours, respectively. Results: In intravenous tenecteplase-treated patients, mildly decreased renal function (OR 3.10; 95% CI: 1.41 to 6.78) and moderately to severely decreased renal function (OR: 8.03; 95% CI: 2.76 to 23.38) showed an association with a higher risk of all-cause mortality but not with sICH incidence compared with normal renal function. Among patients administered intravenous alteplase, those with a moderate-to-severe decrease in renal function exhibited an elevated risk of sICH (adjusted OR: 10.01; 95% CI: 1.61 to 62.15) and all-cause mortality (adjusted OR: 4.54; 95% CI: 1.48 to 13.91). Comparative treatment effects between tenecteplase and alteplase according to renal function grades showed no heterogeneity. Conclusions: A significant correlation was noted between kidney dysfunction and unfavourable outcomes in individuals with AIS who received treatment with either tenecteplase or alteplase.


  • Variants within the LPL gene confer susceptility to diabetic kidney disease and rapid decline in kidney function in Chinese patients with type 2 diabetes

    by Yu Wu, Si Cheng, Hongqiu Gu, Kaixuan Yang, Zhe Xu, Xia Meng, Yilong Wang, Yong Jiang, Hao Li, Yilun Zhou, et al.

    Aim: To examine the association between lipoprotein lipase ( LPL ) polymorphisms and susceptibility to diabetic kidney disease (DKD) and early renal function decline in Chinese patients with type 2 diabetes (T2D). Methods: The association of eight LPL single nucleotide polymorphisms (SNPs) with DKD was analysed in 2793 patients with T2D from the third China National Stroke Registry. DKD was defined as either an urine albumin‐to‐creatinine ratio (UACR) of 30 mg/g or higher at baseline and 3 months, or an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m 2 at baseline and 3 months. Rapid decline in kidney function (RDKF) was defined as a reduction in the eGFR of 3 mL/min/1.73 m 2 or greater per year. Logistic regression models were used to evaluate the association of LPL SNP and DKD with an additive model. Results: The SNPs rs285 C>T (OR = 1.40, P = .0154), rs328 C>G (OR = 2.24, P = .0104) and rs3208305 A>T (OR = 1.85, P = .0015) were identified to be significantly associated with DKD defined by eGFR. Among 1241 participants with follow‐up data, 441 (35.5%) showed RDKF over a mean follow‐up period of 1 year, and the rs285 C allele was associated with higher odds of RDKF (OR = 1.31, 95% CI 1.04‐1.66; P = .025) after adjustment for multiple variables. Conclusions: These results suggest that LPL ‐related SNPs are new candidate factors for conferring susceptibility to DKD and may promote rapid loss of renal function in Chinese patients with T2D.


  • Open Access

    Association between Reduced estimated Glomerular Filtration Rate and Cardiac Structure and Function in Patients with Essential Hypertension

    by Liying Mu, Lu Chen, Juan du, Hua Jiang, Caixia Guo, Zening Jin, Yu Wu

    Objectives To investigate the relationship between small reductions in estimated glomerular filtration rate (eGFR) and cardiac structure and function in patients with essential hypertension. Methods The study group included 565 patients with essential hypertensive. eGFR was calculated by EPI equation and cardiac structure and function were assessed using echocardiography. The participants were divided into three groups: eGFR ≥90 mL/min /1.73 m2, 60-89 mL/min/1.73 m2, and 30-59 mL/min /1.73 m2. Pearson correlation analysis and multiple stepwise linear regression analysis were performed to evaluate associations between eGFR and echocardiogram parameters. Results Compared with patients with eGFR ≥ 90 mL/min/ 1.73 m2, those with eGFR 60-89 mL/min/ 1.73 m2 and 30-59 mL/min/ 1.73 m2 had higher left ventricular end-diastolic diameter (LVEDD) (p=0.019), mitral valve E wave (p=0.004), left atrial diameter (LAD) (p=0.001), right atrial diameter (RAD) (p=0.001), right ventricular diameter (RVD) (p=0.001) and lower left ventricular ejection fraction (LVEF) (p=0.01). After further adjustment for traditional cardiovascular risk factors including systolic and diastolic blood pressure, BMI, diabetes, dyslipidemia and smoking, eGFR was still associated with LVEF (p<0.001), LAD (p<0.001) and RAD (p=0.003). Conclusion Among patients with essential hypertension, even mildly reduced renal function is independently associated with greater cardiac remodeling, indicated by left atrial and right atrial enlargement, and worse left ventricular systolic function.

  • Open Access

    Association between mean platelet volume and pulmonary embolism: a systematic review and meta-analysis

    by Wenyi Lin, Yu Wu, Xuan Lu, Yu Hu

    Platelet activation plays an important role in the progression of pulmonary embolism (PE). Mean platelet volume (MPV) can serve as a marker of platelet activity in patients with PE. Many studies have reported different results regarding the relationship. Therefore, we aimed to perform a systematic review and meta-analysis to evaluate the relationship between MPV and PE. Two reviewers independently searched relevant articles in databases from inception to April 21, 2021 and identified all studies on MPV and PE as the outcomes of interest. Further, we selected studies meeting the criteria and extracted the data. Of the 2505 publications identified, we included 18 studies after screening. Results showed MPV was significantly higher in patients with PE (0.83 fL, 95% CI: 0.38-1.28, P<0.001) than in controls. The mean difference in MPV between those who died and survivors of PE was 1.23 fL (95% CI: 0.96-1.51, P<0.001). Hence, an increased MPV is associated with PE. MPV could be a useful tool to predict the occurrence and death risk of PE together with other risk factors.


  • Arterial spin labeling–MR may be an alternative to SPECT for evaluating cerebral perfusion in patients with unilateral middle cerebral artery stenosis

    by Jingyuan Ya, Da Zhou, Jiayue Ding, Gary B. Rajah, Ye Wu, Xiaoxu Yang, Yaqin Hou, Kexin Jin, Liqun Pan, Yu Wu, et al.

    Cerebral blood flow (CBF) mapping of single-photon emission tomography (SPECT) is considered a gold standard for evaluating cerebral perfusion. However, invasiveness, high costs and strict technica...


  • Open Access

    Correlation between carotid intima‑media roughness and cardiovascular risk factors

    by Yu Wu, Xuan Lu, Li Zhang, Xinyao Cheng, Li Yuan, Mingxing Xie, Qing Lv

    Arterial intima‑media roughness (IMR) may indicate an early manifestation of atherosclerosis. To date, few studies have been performed to quantitatively evaluate carotid IMR by ultrasonography (US). The aim of the present study was to analyze the effect of cardiovascular risk factors on carotid IMR. A total of 185 subjects were enrolled for US examination of carotid arteries. Carotid intima‑media thickness (IMT) and IMR were measured in US images by a novel automatic software. According to the number of combined high‑risk factors for coronary heart disease, subjects were assigned to four groups (risk groups 0, 1, 2 and 3+). IMR was lowest in risk group 0 (32.9±2.7 µm), higher in risk group 1 (64.5±6.9 µm; P<0.01 vs. risk group 0) and highest in risk groups 2 and 3+ (89.1±7.4 and 92.0±6.7 µm, respectively; P<0.01 vs. risk groups 0 and 1). According to a multivariate regression analysis, age, systolic blood pressure, smoking status and the triglyceride/high‑density lipoprotein cholesterol ratio were significant predictors of IMR. There was a progressive increase in carotid artery plaque with increasing tertiles of IMR (4.9, 33.9 and 53.2% in tertiles 1, 2 and 3, respectively; P<0.05). Compared with that of subjects in the lowest tertile of IMR, those in the highest tertile had a significantly elevated risk of the presence of plaque in the carotid tree (odds ratio=10.61, 95%CI: 2.15‑52.49, P=0.004). Quantification of carotid IMR from US images with this software is feasible, and carotid IMR, which may help estimate the extent of atherosclerosis, may be used as a complementary factor to stratify patients with cardiovascular risk factors.